Your results for

Filter by

Filter by
Results

Filter by

Content type
Key content topics
Key audience
Top cancer treatments

Local tumour control and radiation side effects for fractionated stereotactic photon beam radiotherapy compared to proton beam therapy in uveal melanoma.

29/04/2024
/ Publications
/
Pencil Beam Scanning - PBS

Published in the Green Journal, this study compared two cohorts of each 153 patients with uveal melanoma treated with fractionated stereotactic photon-RT (50 Gy...

Side Effects of Proton Beam Radiotherapy Treatment on Iris Melanoma.

01/09/2023
/ Publications

This study demonstrated PBR a successful treatment option with a high tumor control rate and low complication profile. 149 eyes of 149 patients were treated...

PTCOG Gastrointestinal Subcommittee Lower Gastrointestinal Tract Malignancies Consensus Statement.

30/10/2024
/ Publications

Lower gastrointestinal (LGI) tract malignancies arise from the rectum and anal canal. The PTCOG GI Subcommittee conducted a systematic literature review, and...

Moderately hypofractionated proton beam therapy for localized prostate cancer: 5-year outcomes of a phase II trial.

30/10/2024
/ Publications

This study from Japan included 100 patients with localized prostate cancer treated with moderately hypofractionated PT (70 GyRBE in 28 fractions) for evaluation...

Effectiveness and Safety of Carbon Ion Radiotherapy in Solid Tumors: A Systematic Review and Meta-Analysis.

30/10/2024
/ Publications

This systematic review and meta-analysis included 34 comparative studies and evaluated the effectiveness of carbon ion radiotherapy (CIRT) in patients with...

Prostate Advanced Radiation Technologies Investigating Quality of Life (PARTIQoL): Phase III Randomized Clinical Trial of Proton Therapy vs. IMRT for Localized Prostate Cancer.

05/11/2024
/ Publications

PARTIQoL is a multi-center phase 3 randomized trial comparing proton and photon for intermediate- or low-risk prostate cancer with a primary endpoint to compare...

Setting the Stage: Feasibility and Baseline Characteristics in the PARTIQoL Trial Comparing Proton Therapy Versus Intensity Modulated Radiation Therapy for Localized Prostate Cancer.

05/11/2024
/ Publications

Published in the Red Journal, this is a report from the PARTIQoL trial focusing on describing the trial design, patient baseline features, clinical details of...

Secondary Cancer in Prostate Cancer Patients Treated With Advanced External Beam Radiation Therapy.

05/11/2024
/ Publications

Using data of 133,898 N0M0 prostate cancer cases from the National Cancer Database, this study compared second primary cancer (SPC) probabilities among those...

Risk of radiation-induced second malignant neoplasms from photon and proton radiotherapy in paediatric abdominal neuroblastoma

08/07/2021
/ Publications
/
Secondary cancer

This study compared the carcinogenic risk associated with 3D-CRT, IMAT and PBS-PT)in the treatment of pediatric abdominal neuroblastoma. The risk of radiation...

Trends and variations in utilization and costs of radiotherapy for prostate cancer: A SEER medicare analysis from 2007 through 2016

08/02/2021
/ Publications
/
IMPT

Based on the SEER database, this study reported that for Medicare beneficiaries with a first-time diagnosis of prostate cancer, the utilization of IMRT, proton...